Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomized controlled trial
Background Because treatment with third-generation cephalosporins is associated with slow clinical improvement and high relapse burden for enteric fever, whereas the fluoroquinolone gatifloxacin is associated with rapid fever clearance and low relapse burden, we postulated that gatifloxacin would b...
שמור ב:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
פורמט: | Technical Report |
שפה: | en_US |
יצא לאור: |
Lancet Infect Dis 2016
2016
|
נושאים: | |
גישה מקוונת: | http://103.69.126.140:8080/handle/123456789/818 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
היה/י הראשונ/ה לכתוב הערה!